Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia
- PMID: 38248833
- PMCID: PMC10819534
- DOI: 10.3390/metabo14010030
Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia
Abstract
Recent data described that patients with lysosomal storage disorders (LSDs) may have clinical schizophrenia (SCZ) features. Disruption of lipid metabolism in SCZ pathogenesis was found. Clinical features of schizophrenia (SCZ) have been demonstrated in patients with several lysosomal storage disorders (LSDs). Taking into account the critical role of lysosomal function for neuronal cells' lysosomal dysfunction could be proposed in SCZ pathogenesis. The current study analyzed lysosomal enzyme activities and the alpha-synuclein level in the blood of patients with late-onset SCZ. In total, 52 SCZ patients with late-onset SCZ, 180 sporadic Parkinson's disease (sPD) patients, and 176 controls were recruited. The enzymatic activity of enzymes associated with mucopolysaccharidosis (alpha-L-Iduronidase (IDUA)), glycogenosis (acid alpha-glucosidase (GAA)) and sphingolipidosis (galactosylceramidase (GALC), glucocerebrosidase (GCase), alpha-galactosidase (GLA), acid sphingomyelinase (ASMase)) and concentration of lysosphingolipids (hexosylsphingosine (HexSph), globotriaosylsphingosine (LysoGb3), and lysosphingomyelin (LysoSM)) were measured using LC-MS/MS. The alpha-synuclein level was estimated in magnetically separated CD45+ blood cells using the enzyme-linked immunosorbent assay (ELISA). Additionally, NGS analysis of 11 LSDs genes was conducted in 21 early-onset SCZ patients and 23 controls using the gene panel PGRNseq-NDD. Decreased ASMase, increased GLA activities, and increased HexSpn, LysoGb3, and LysoSM concentrations along with an accumulation of the alpha-synuclein level were observed in late-onset SCZ patients in comparison to the controls (p < 0.05). Four rare deleterious variants among LSDs genes causing mucopolysaccharidosis type I (IDUA (rs532731688, rs74385837) and type III (HGSNAT (rs766835582)) and sphingolipidosis (metachromatic leukodystrophy (ARSA (rs201251634)) were identified in five patients from the group of early-onset SCZ patients but not in the controls. Our findings supported the role of sphingolipid metabolism in SCZ pathogenesis. Aberrant enzyme activities and compounds of sphingolipids associated with ceramide metabolism may lead to accumulation of alpha-synuclein and may be critical in SCZ pathogenesis.
Keywords: Parkinson’s disease; alpha-synuclein; hydrolase activity; lysosomal storage disorder genes; schizophrenia; sphingolipids.
Conflict of interest statement
Yury A. Barbitoff and Oleg S. Glotov work both in the institute and in the company. Yury Barbitoff and Oleg Glotov are employees of Cerbalab Ltd (Saint Petersburg, Russia, https://cerbalab.ru). The paper reflects the views of the scientists, and not the company.
Figures
Similar articles
-
The Effect of p.G2019S Mutation in the LRRK2 Gene on the Activity of Lysosomal Hydrolases and the Clinical Features of Parkinson's Disease Associated with p.N370S Mutation in the GBA1 Gene.J Integr Neurosci. 2024 Jan 16;23(1):16. doi: 10.31083/j.jin2301016. J Integr Neurosci. 2024. PMID: 38287861
-
LRRK2 exonic variants are associated with lysosomal hydrolase activities and lysosphingolipid alterations in Parkinson's disease.Gene. 2023 Oct 5;882:147639. doi: 10.1016/j.gene.2023.147639. Epub 2023 Jul 18. Gene. 2023. PMID: 37473971
-
Impaired Sphingolipid Hydrolase Activities in Dementia with Lewy Bodies and Multiple System Atrophy.Mol Neurobiol. 2022 Apr;59(4):2277-2287. doi: 10.1007/s12035-021-02688-0. Epub 2022 Jan 23. Mol Neurobiol. 2022. PMID: 35066761
-
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease.J Clin Med. 2020 Feb 21;9(2):594. doi: 10.3390/jcm9020594. J Clin Med. 2020. PMID: 32098196 Free PMC article. Review.
-
Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.J Neurochem. 2016 Oct;139 Suppl 1:198-215. doi: 10.1111/jnc.13517. Epub 2016 Feb 10. J Neurochem. 2016. PMID: 26860955 Review.
Cited by
-
How do different cell populations orchestrate myelin regeneration?Biochem Soc Trans. 2025 Jun 30;53(3):653-669. doi: 10.1042/BST20231085. Biochem Soc Trans. 2025. PMID: 40552465 Free PMC article. Review.
-
Acid sphingomyelinase modulates anxiety-like behavior likely through toll-like receptor signaling pathway.Mol Brain. 2025 Feb 4;18(1):8. doi: 10.1186/s13041-025-01178-x. Mol Brain. 2025. PMID: 39905541 Free PMC article.
-
Alpha Synuclein Toxicity and Non-Motor Parkinson's.Cells. 2024 Jul 27;13(15):1265. doi: 10.3390/cells13151265. Cells. 2024. PMID: 39120295 Free PMC article. Review.
References
-
- Howrigan D.P., Rose S.A., Samocha K.E., Fromer M., Cerrato F., Chen W.J., Churchhouse C., Chambert K., Chandler S.D., Daly M.J., et al. Exome Sequencing in Schizophrenia-Affected Parent–Offspring Trios Reveals Risk Conferred by Protein-Coding de Novo Mutations. Nat. Neurosci. 2020;23:185–193. doi: 10.1038/s41593-019-0564-3. - DOI - PMC - PubMed
-
- Oh J., Shen G., Nan G., Kim J.M., Jung K.Y., Jeon B. Comorbid Schizophrenia and Parkinson’s Disease: A Case Series and Brief Review. Neurol. Asia. 2017;22:139–142.
-
- Pardiñas A.F., Holmans P., Pocklington A.J., Escott-Price V., Ripke S., Carrera N., Legge S.E., Bishop S., Cameron D., Hamshere M.L., et al. Common Schizophrenia Alleles Are Enriched in Mutation-Intolerant Genes and in Regions under Strong Background Selection. Nat. Genet. 2018;50:381–389. doi: 10.1038/s41588-018-0059-2. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous